Rivia raised $15M in a Series A round to bring clinical trials into the agentic AI era.
- Amount
- $15M
- Stage
- Series A
- Announced
- 18 March 2026
- Lead
- Earlybird
- Other investors
- Defiant, Speedinvest, Amino Collective, Nina Capital
- Use of funds
- Supports team growth, scaling product development, and expanding internationally, with a particular focus on the US market.
- Checked
- Amount and date matched across 2 press sources